Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study.
about
Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B studyMolecular mechanisms of ETS transcription factor-mediated tumorigenesisThe oncogenic role of the ETS transcription factors MEF and ERGFLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications.Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B studyFavorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise reviewERG transcriptional networks in primary acute leukemia cells implicate a role for ERG in deregulated kinase signalingHigh expression of IGFBP2 is associated with chemoresistance in adult acute myeloid leukemiaE-26 Transformation-specific Related Gene Expression and Outcomes in Cytogenetically Normal Acute Myeloid Leukemia: A Meta-analysis.IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells.Identification of E74-like factor 1 (ELF1) as a transcriptional regulator of the Hox cofactor MEIS1.An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemiaRole of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.CDKN1B, encoding the cyclin-dependent kinase inhibitor 1B (p27), is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemia.FLT3 inhibitors in the treatment of acute myeloid leukemia: the start of an era?Promiscuous partnerships in Ewing's sarcoma.Identification of genes transcriptionally responsive to the loss of MLL fusions in MLL-rearranged acute lymphoblastic leukemia.Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.Early lineage priming by trisomy of Erg leads to myeloproliferation in a Down syndrome model.Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia.Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B study.Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B study.Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.Informative gene selection and the direct classification of tumors based on relative simplicity.Heritable polymorphism predisposes to high BAALC expression in acute myeloid leukemiaA novel mouse model identifies cooperating mutations and therapeutic targets critical for chronic myeloid leukemia progression.Abnormal developmental control of replication-timing domains in pediatric acute lymphoblastic leukemia.Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemia.Current therapeutic strategies for acute myeloid leukaemia.An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype.Guidelines on the management of acute myeloid leukaemia in adults.A novel IGH@ gene rearrangement associated with CDKN2A/B deletion in young adult B-cell acute lymphoblastic leukemia.High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CAL
P2860
Q24643738-66E93DDA-D85D-46B4-8770-1AC6E4E70DE9Q26829833-8BA22B5A-303B-46AD-A08D-BA8A4659A110Q27694537-837586D7-DF80-409A-8365-CBB8C9D7D1ACQ27851415-5F6853E6-732A-41B8-9BE3-262BF86B0D96Q27851436-6A4506C8-A858-4E02-B425-0B72747CED28Q27851545-041D3378-7DFE-4699-B8DB-93635BE56047Q28301344-BABB1A70-BB09-4F2B-A987-B4652D7EF447Q28484833-2DD8C76C-4B7E-4E62-9253-FA312C0AF4EDQ33623126-C837824E-A7AF-4696-B67C-3F783FF22335Q33776896-F3C16A57-84E2-450D-95D4-20015643A568Q33897586-75DD4B7F-DC87-4D37-BB56-6BC626137236Q34048276-7C461253-3A69-4535-853F-DED7F538FBFDQ34052614-B1120629-9ADD-4924-911B-EC0BEE8EA562Q34091302-8226D0EE-3C47-4C85-B7AC-7E03FF61FD1EQ34124147-C7F5531E-411E-4AB3-A599-DFB03961828AQ34197535-65E2B635-A696-4115-8C24-A9C228E24373Q34388531-1D0AA2FB-E0A0-4AC3-B137-FC3EF9CF53DBQ34477821-38A6FF60-E723-4CBD-B91D-373A698DB057Q34541748-120E4418-7D22-4E15-9DBF-44A6AFE731A9Q35018518-59BC17AF-D70E-4CE2-AF48-3EBFE1C00460Q35048217-33E114E1-BD66-4C2D-AE8E-C70B5AFB24F9Q35188770-300CBB33-34A2-48DF-83C4-FC4E46C3A81DQ35202285-EED64D04-7A3E-4C7F-B9FA-6048483EFDD9Q35265946-11B2B48C-C60A-4E67-A176-FE9E99BDB7E3Q35606539-43B68C5A-696E-4823-AA86-DFB01239DC74Q35615901-818677F1-E307-49EF-A869-D6FE2EADE21FQ35794120-C13CF569-16EF-4AFF-AF40-3D67EEA9155CQ35839909-3677DB5D-ABFD-4AE4-9881-AD6728770F9BQ35848995-548CA2F7-5958-493C-A8B3-886C422F0BB6Q35849784-264457CC-1308-499B-8BC3-C6F7F67D24BCQ35899607-BD1BFE70-1AEE-459C-B828-4A20C9540345Q35922032-0577CE80-9062-4811-8160-17AE71829C28Q36080675-0FA54A68-4345-486F-9B85-8B93A094E0EFQ36285367-5AAEBC63-011C-48BD-AC0E-F5442F1DC94FQ36445921-83CCC729-CACB-4A56-AC0B-E7D4F28CE7D2Q36539598-3D1A0CBC-BBF1-4700-901F-7A49FF6C60ECQ36629521-02EA23B4-4B21-43BB-A6B7-4E9D145AAAE9Q36630107-4D759A97-034D-4C83-9F83-00EEBACA8AB0Q36640716-694DE0E9-05D7-42F1-B7BE-2135EDA1278CQ36677320-D4FA37B8-C770-4DE3-BB2E-B31DE26080D4
P2860
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Overexpression of the ETS-rela ...... er and Leukemia Group B study.
@en
type
label
Overexpression of the ETS-rela ...... er and Leukemia Group B study.
@en
prefLabel
Overexpression of the ETS-rela ...... er and Leukemia Group B study.
@en
P2093
P50
P921
P356
P1476
Overexpression of the ETS-rela ...... er and Leukemia Group B study.
@en
P2093
Amy S Ruppert
Andrew J Carroll
Bayard L Powell
Claudia D Baldus
Colin G Edwards
Danilo Perrotti
James W Vardiman
Jonathan E Kolitz
Joseph O Moore
Maria R Baer
P304
P356
10.1200/JCO.2005.03.6137
P407
P577
2005-11-07T00:00:00Z